- Home
- GREE vs RNXT Comparison
GREE vs RNXT Comparison
Compare GREE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GREE
- RNXT
- Stock Information
- Founded
- GREE 1937
- RNXT 2012
- Country
- GREE United States
- RNXT United States
- Employees
- GREE N/A
- RNXT N/A
- Industry
- GREE Investment Bankers/Brokers/Service
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- GREE Finance
- RNXT Health Care
- Exchange
- GREE Nasdaq
- RNXT Nasdaq
- Market Cap
- GREE 25.9M
- RNXT 24.0M
- IPO Year
- GREE N/A
- RNXT 2021
- Fundamental
- Price
- GREE $1.92
- RNXT $1.03
- Analyst Decision
- GREE Strong Buy
- RNXT Strong Buy
- Analyst Count
- GREE 1
- RNXT 3
- Target Price
- GREE $4.00
- RNXT $6.13
- AVG Volume (30 Days)
- GREE 127.1K
- RNXT 50.6K
- Earning Date
- GREE 11-12-2024
- RNXT 11-12-2024
- Dividend Yield
- GREE N/A
- RNXT N/A
- EPS Growth
- GREE N/A
- RNXT N/A
- EPS
- GREE N/A
- RNXT N/A
- Revenue
- GREE $72,911,000.00
- RNXT N/A
- Revenue This Year
- GREE N/A
- RNXT N/A
- Revenue Next Year
- GREE N/A
- RNXT N/A
- P/E Ratio
- GREE N/A
- RNXT N/A
- Revenue Growth
- GREE 7.59
- RNXT N/A
- 52 Week Low
- GREE $1.62
- RNXT $0.53
- 52 Week High
- GREE $9.26
- RNXT $2.35
- Technical
- Relative Strength Index (RSI)
- GREE 51.28
- RNXT 47.89
- Support Level
- GREE $1.73
- RNXT $1.00
- Resistance Level
- GREE $2.10
- RNXT $1.09
- Average True Range (ATR)
- GREE 0.13
- RNXT 0.10
- MACD
- GREE 0.02
- RNXT -0.00
- Stochastic Oscillator
- GREE 52.63
- RNXT 22.80
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc. owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the global bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.